Rohan Palekar rides in as Avanir CCO
This article was originally published in Scrip
Avanir Pharmaceuticals, a biopharmaceutical company developing innovative medicines for CNS disorders, has appointed Rohan Palekar senior vice-president and chief commercial officer. Mr Palekar previously served as CCO for Medivation, where he was responsible for all commercial activities as well as CMC & manufacturing and public relations. Before that, he spent over 16 years at Johnson & Johnson in various senior commercial roles.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.